Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-01-08

Clinical Trial Update: Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) [Phase 4]

View source ↗

Summary

Phase 4 trial of letrozole for frozen embryo transfer in PCOS patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

Sponsor: CRG UZ Brussel | Conditions: Infertility, Female, Polycystic Ovary Syndrome | Phase 4 | Status: WITHDRAWN